• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Software subscribers order online from own Web sites

Article

Rouses Point, NY –Imperial Optical Inc. has entered into a strategic partnership with DaVinci Laboratories of Vermont that will ultimately let patients of subscribers to Imperial Optical's ECP WebSolutions order their eye-health supplements directly from their practitioners' Web sites.

Rouses Point, NY–Imperial Optical Inc. has entered into a strategic partnership with DaVinci Laboratories of Vermont that will ultimately let patients of subscribers to Imperial Optical's ECP WebSolutions order their eye-health supplements directly from their practitioners' Web sites.

Imperial Optical is a contact lens distributor; DaVinci Laboratories, a division of FoodScience Corp., offers natural supplements and nutraceuticals, including versions to support eye health.

The companies hope to tap into the $20 billion U.S. nutraceutical market–roughly 10 times that of the U.S. contact lens market–by making the eye/vision health line of DaVinci products available online to ECP WebSolutions subscribers at no additional cost. Consumers will be able to purchase directly from the ECP Web site using their own credit cards, and the software will allow practices to set the sale price of the DaVinci products.

Related Videos
Video 1 - "Challenging the Definition of Dry Eye- Interpreting Diagnostic Tests"
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.